PR Newswire Clinical TrialsOriginal article
Vantis Vascular Receives FDA Clearance for 6F CrossFAST Model
RegulatoryapprovedCrossFASTCrossFAST 6FPositive
AI Analysis
Summary
Vantis Vascular received FDA clearance for a new 6 French model of its CrossFAST device, which accommodates a broader range of devices while maintaining the integrated design of the original model.
Outcome Details
FDA clearance for 6F CrossFAST model. New model accommodates broader range of devices while maintaining integrated design and deliverability.
Importance:6/10
Sentiment:
0.80
FDA clearancemedical devicevascular interventionproduct expansion
Read the original article
Published by PR Newswire Clinical Trials on October 13, 2026 8:10 PM